Catheter Precision FY2024 revenue $420K, net loss $16.6M; Q4 rev $149K up 55% QoQ

Catheter Precision, Inc.

Full year 2024 revenue $420 thousand; Q4 2024 revenue $149 thousand, sequential increase of 55% over Q3.
Net loss for 2024 was $16.6 million, of which $7.5 million were non-cash charges; Q4 net loss $5.6 million.
LockeT vascular closure device first sales began Q2 2024 and grew sequentially; 26 institutions evaluated by year-end.
CE Mark for LockeT anticipated Q2 2025 with EU sales expected to start Q3 2025.
New Chief Commercial Officer appointed Q2 2024; majority of sales team replaced and trained by Q3 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.